Deadline for applications: 14 February 2019
Download Award Information
This Research Award will support medical research projects to build capacity and foster the development of research in the area of alpha-1 anti-trypsin deficiency through the support of pilot studies, proof of concept and feasibility studies.
The goal of this award is to improve outcomes and quality of life for individuals with alpha-1 anti-trypsin deficiency, and will therefore focus on research into alpha-1 anti-trypsin deficiency relating to lung disease, with encouragement (without exclusion) of research into the specific areas of:
The one-year award shall be to the value of AU $60,000, with $40,000 paid upfront and the remaining $20,000 paid on completion of a report or publication.
To be eligible for this travel grant, the applicant must:
 Financial member of TSANZ who has obtained the support of a proposer and seconder, and has been endorsed by the TSANZ Board
The following conditions must be meet by members receiving this award:
Note: These conditions must be met to remain eligible for future award rounds.
Applications will be assessed by members of the TSANZ Research Committee according to the following criteria:
In the event of there being no suitable applicants the Research Award will not be awarded.
The award will be presented at the 2019 TSANZ ASM, however the successful applicant will be notified prior to the ASM.